Systemic hedgehog inhibitors to treat locally advanced basal cell carcinomas of the head-neck region: A retrospective study.
作者信息
Villani Alessia, Costa Claudia, Fabbrocini Gabriella, Scalvenzi Massimiliano
机构信息
Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
出版信息
Dermatol Ther. 2021 Sep;34(5):e15036. doi: 10.1111/dth.15036. Epub 2021 Jul 1.
Abstract
摘要
相似文献
1
Systemic hedgehog inhibitors to treat locally advanced basal cell carcinomas of the head-neck region: A retrospective study.用于治疗头颈部局部晚期基底细胞癌的系统性刺猬蛋白抑制剂：一项回顾性研究。
Dermatol Ther. 2021 Sep;34(5):e15036. doi: 10.1111/dth.15036. Epub 2021 Jul 1.
2
High-Risk Recurrence Basal Cell Carcinoma: Focus on Hedgehog Pathway Inhibitors and Review of the Literature.高危复发性基底细胞癌：聚焦 Hedgehog 通路抑制剂及文献复习。
Chemotherapy. 2020;65(1-2):2-10. doi: 10.1159/000509156. Epub 2020 Aug 10.
3
Sonic Hedgehog Pathway Inhibition in the Treatment of Advanced Basal Cell Carcinoma.Sonic Hedgehog 通路抑制在晚期基底细胞癌治疗中的应用。
Curr Treat Options Oncol. 2019 Nov 26;20(11):84. doi: 10.1007/s11864-019-0683-9.
4
Hedgehog Pathway Inhibition for the Treatment of Basal Cell Carcinoma. hedgehog 通路抑制治疗基底细胞癌。
Target Oncol. 2019 Jun;14(3):253-267. doi: 10.1007/s11523-019-00648-2.
5
[Hedgehog inhibitors. New promising treatment of advanced basal cell carcinoma].[刺猬信号通路抑制剂。晚期基底细胞癌的新的有前景的治疗方法]
Lakartidningen. 2013;110(17-18):886-8.
6
Hedgehog Pathway Inhibition.刺猬通路抑制。
Cell. 2016 Feb 25;164(5):831. doi: 10.1016/j.cell.2016.02.021.
7
Vismodegib: a hedgehog pathway inhibitor for locally advanced and metastatic basal cell carcinomas.维莫德吉：一种用于局部晚期和转移性基底细胞癌的刺猬信号通路抑制剂。
J Drugs Dermatol. 2013 Oct;12(10 Suppl):s154-5.
8
Hedgehog antagonist GDC-0449 is effective in the treatment of advanced basal cell carcinoma. hedgehog 拮抗剂 GDC-0449 对晚期基底细胞癌的治疗有效。
Laryngoscope. 2010 Dec;120(12):2456-9. doi: 10.1002/lary.21145.
9
Hedgehog signaling pathway: a novel target for cancer therapy: vismodegib, a promising therapeutic option in treatment of basal cell carcinomas.刺猬信号通路：癌症治疗的新靶点：维莫德吉，治疗基底细胞癌的一种有前景的治疗选择。
Indian J Pharmacol. 2014 Jan-Feb;46(1):3-12. doi: 10.4103/0253-7613.124884.
10
Induction cisplatin-based chemotherapy and following radiotherapy in locally advanced basal cell carcinoma of the skin.局部晚期皮肤基底细胞癌的顺铂诱导化疗及后续放疗
Acta Oncol. 2012 Sep;51(7):952-4. doi: 10.3109/0284186X.2012.670265. Epub 2012 Apr 4.
引用本文的文献
1
Sonidegib in the Treatment of Locally Advanced Basal Cell Carcinoma: a Retrospective Study.索尼替尼治疗局部晚期基底细胞癌：一项回顾性研究。
Acta Derm Venereol. 2022 May 23;102:adv00740. doi: 10.2340/actadv.v102.1995.
本文引用的文献
1
Management of locally advanced basal cell carcinoma treated with sonidegib: The experience of an Italian reference hospital.用索尼德吉治疗局部晚期基底细胞癌的管理：一家意大利参考医院的经验。
Dermatol Ther. 2020 Nov;33(6):e14511. doi: 10.1111/dth.14511. Epub 2020 Nov 17.
2
Complete remission of an advanced basal cell carcinoma after only 3-month treatment with sonidegib: Report of a case and drug management during COVID-19 pandemic.使用索尼德吉仅治疗3个月后晚期基底细胞癌完全缓解：1例报告及COVID-19大流行期间的药物管理
Dermatol Ther. 2020 Nov;33(6):e14200. doi: 10.1111/dth.14200. Epub 2020 Sep 14.
3
High-Risk Recurrence Basal Cell Carcinoma: Focus on Hedgehog Pathway Inhibitors and Review of the Literature.高危复发性基底细胞癌：聚焦 Hedgehog 通路抑制剂及文献复习。
Chemotherapy. 2020;65(1-2):2-10. doi: 10.1159/000509156. Epub 2020 Aug 10.
4
Arsenic Trioxide, Itraconazole, All-Trans Retinoic Acid and Nicotinamide: A Proof of Concept for Combined Treatments with Hedgehog Inhibitors in Advanced Basal Cell Carcinoma.三氧化二砷、伊曲康唑、全反式维甲酸和烟酰胺：晚期基底细胞癌中与刺猬信号通路抑制剂联合治疗的概念验证
Biomedicines. 2020 Jun 11;8(6):156. doi: 10.3390/biomedicines8060156.
5
Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma.索尼德吉：治疗晚期基底细胞癌的安全性与有效性
Dermatol Ther (Heidelb). 2020 Jun;10(3):401-412. doi: 10.1007/s13555-020-00378-8. Epub 2020 Apr 15.
6
Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinion.索纳替尼和维莫德吉治疗局部晚期基底细胞癌患者：联合专家意见
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):1944-1956. doi: 10.1111/jdv.16230. Epub 2020 Mar 4.
7
Long-Term Efficacy of Vismodegib After its Withdrawal and Patients' Health-Related Quality of Life Using the Dermatology Life Quality Index (DLQI).维莫德吉停药后的长期疗效以及使用皮肤病生活质量指数（DLQI）评估患者的健康相关生活质量。
Dermatol Ther (Heidelb). 2019 Dec;9(4):719-724. doi: 10.1007/s13555-019-00323-4. Epub 2019 Sep 10.
8
Oral Hedgehog Pathway Inhibition as a Means for Ocular Salvage in Locally Advanced Intraorbital Basal Cell Carcinoma.口服 Hedgehog 信号通路抑制作为局部晚期眼眶基底细胞癌眼部挽救治疗的一种手段
Dermatol Surg. 2019 Jan;45(1):17-25. doi: 10.1097/DSS.0000000000001640.
9
Implementation of Systemic Hedgehog Inhibitors in Daily Practice as Neoadjuvant Therapy.系统 Hedgehog 抑制剂在新辅助治疗中的日常实践中的应用。
J Natl Compr Canc Netw. 2017 Apr;15(4):537-543. doi: 10.6004/jnccn.2017.0051.
Zotero 插件